These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 33754932)

  • 1. Real-world evidence costs of allergic rhinitis and allergy immunotherapy in the commercially insured United States population.
    Tkacz JP; Rance K; Waddell D; Aagren M; Hammerby E
    Curr Med Res Opin; 2021 Jun; 37(6):957-965. PubMed ID: 33754932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-world mapping of allergy immunotherapy in the United States: The argument for improving adherence.
    Stone B; Rance K; Waddell D; Aagren M; Hammerby E; Tkacz JP
    Allergy Asthma Proc; 2021 Jan; 42(1):55-64. PubMed ID: 33357262
    [No Abstract]   [Full Text] [Related]  

  • 3. High baseline prevalence of atopic comorbidities and medication use in children treated with allergy immunotherapy in the REAl-world effeCtiveness in allergy immunoTherapy (REACT) study.
    Fritszching B; Porsbjerg C; Buchs S; Larsen JR; Freemantle N; Contoli M
    Front Pediatr; 2023; 11():1136942. PubMed ID: 37063677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allergy immunotherapy: reduced health care costs in adults and children with allergic rhinitis.
    Hankin CS; Cox L; Bronstone A; Wang Z
    J Allergy Clin Immunol; 2013 Apr; 131(4):1084-91. PubMed ID: 23375206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Executive Summary of Clinical Practice Guideline on Immunotherapy for Inhalant Allergy.
    Gurgel RK; Baroody FM; Damask CC; Mims JW; Ishman SL; Baker DP; Contrera KJ; Farid FS; Fornadley JA; Gardner DD; Henry LR; Kim J; Levy JM; Reger CM; Ritz HJ; Stachler RJ; Valdez TA; Reyes J; Dhepyasuwan N
    Otolaryngol Head Neck Surg; 2024 Mar; 170(3):635-667. PubMed ID: 38408153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Practice Guideline: Immunotherapy for Inhalant Allergy.
    Gurgel RK; Baroody FM; Damask CC; Mims JW; Ishman SL; Baker DP; Contrera KJ; Farid FS; Fornadley JA; Gardner DD; Henry LR; Kim J; Levy JM; Reger CM; Ritz HJ; Stachler RJ; Valdez TA; Reyes J; Dhepyasuwan N
    Otolaryngol Head Neck Surg; 2024 Mar; 170 Suppl 1():S1-S42. PubMed ID: 38408152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical practice guideline: Allergic rhinitis.
    Seidman MD; Gurgel RK; Lin SY; Schwartz SR; Baroody FM; Bonner JR; Dawson DE; Dykewicz MS; Hackell JM; Han JK; Ishman SL; Krouse HJ; Malekzadeh S; Mims JW; Omole FS; Reddy WD; Wallace DV; Walsh SA; Warren BE; Wilson MN; Nnacheta LC;
    Otolaryngol Head Neck Surg; 2015 Feb; 152(1 Suppl):S1-43. PubMed ID: 25644617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healthcare costs for allergic rhinitis patients on allergy immunotherapy: a retrospective observational study.
    Allen-Ramey F; Mao J; Blauer-Peterson C; Rock M; Nathan R; Halpern R
    Curr Med Res Opin; 2017 Nov; 33(11):2039-2047. PubMed ID: 28737480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost of subcutaneous immunotherapy in a large insured population in the United States.
    Mao J; Heithoff KA; Koep E; Murphy T; Hammerby E
    Curr Med Res Opin; 2019 Feb; 35(2):351-358. PubMed ID: 30091647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-world evidence of subcutaneous allergoid immunotherapy in house dust mite-induced allergic rhinitis and asthma.
    Jutel M; Brüggenjürgen B; Richter H; Vogelberg C
    Allergy; 2020 Aug; 75(8):2050-2058. PubMed ID: 32080856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-world benefits of allergen immunotherapy for birch pollen-associated allergic rhinitis and asthma.
    Wahn U; Bachert C; Heinrich J; Richter H; Zielen S
    Allergy; 2019 Mar; 74(3):594-604. PubMed ID: 30183091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allergy immunotherapy for allergic rhinitis effectively prevents asthma: Results from a large retrospective cohort study.
    Schmitt J; Schwarz K; Stadler E; Wüstenberg EG
    J Allergy Clin Immunol; 2015 Dec; 136(6):1511-1516. PubMed ID: 26371838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allergen immunotherapy and health care cost benefits for children with allergic rhinitis: a large-scale, retrospective, matched cohort study.
    Hankin CS; Cox L; Lang D; Bronstone A; Fass P; Leatherman B; Wang Z
    Ann Allergy Asthma Immunol; 2010 Jan; 104(1):79-85. PubMed ID: 20143650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Comparison of Health Care Resource Utilization and Costs for Patients with Allergic Rhinitis on Single-Product or Free-Combination Therapy of Intranasal Steroids and Intranasal Antihistamines.
    Harrow B; Sedaghat AR; Caldwell-Tarr A; Dufour R
    J Manag Care Spec Pharm; 2016 Dec; 22(12):1426-1436. PubMed ID: 27882840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States.
    Bonafede M; Sapra S; Shah N; Tepper S; Cappell K; Desai P
    Headache; 2018 May; 58(5):700-714. PubMed ID: 29446063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sublingual immunotherapy provides long-term relief in allergic rhinitis and reduces the risk of asthma: A retrospective, real-world database analysis.
    Zielen S; Devillier P; Heinrich J; Richter H; Wahn U
    Allergy; 2018 Jan; 73(1):165-177. PubMed ID: 28561266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term real-world effectiveness of allergy immunotherapy in patients with allergic rhinitis and asthma: Results from the REACT study, a retrospective cohort study.
    Fritzsching B; Contoli M; Porsbjerg C; Buchs S; Larsen JR; Elliott L; Rodriguez MR; Freemantle N
    Lancet Reg Health Eur; 2022 Feb; 13():100275. PubMed ID: 34901915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic burden of atopic manifestations in patients with atopic dermatitis--analysis of administrative claims.
    Suh DC; Sung J; Gause D; Raut M; Huang J; Choi IS
    J Manag Care Pharm; 2007; 13(9):778-89. PubMed ID: 18062729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical care and treatment of allergic rhinitis: a population-based cohort study based on routine healthcare utilization data.
    Schmitt J; Stadler E; Küster D; Wüstenberg EG
    Allergy; 2016 Jun; 71(6):850-8. PubMed ID: 26749452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient characteristics and prescription fill patterns for allergic rhinitis medications, with a focus on montelukast, in a commercially insured population.
    Bollinger ME; Diette GB; Chang CL; Stephenson JJ; Sajjan SG; Fan T; Allen-Ramey FC
    Clin Ther; 2010 Jun; 32(6):1093-102. PubMed ID: 20637964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.